Evidence map›Paper›PMID 38031772›Full record

ReviewInfectious disorders drug targets2024

Diagnosis and Management of Latent Tuberculosis Infection: Updates.

Satish Swain, Arvind Kumar, Vishal Kumar Vishwakarma, Adarsh Aayilliath K, Ankit Mittal, Naveet Wig

Abstract readReview
PubMed Publisher
In one paragraph

Review in Infectious disorders drug targets, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Satish SwainDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Arvind KumarDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Vishal Kumar VishwakarmaDepartment of Pharmacology, All India Institute of Medical Sciences, Delhi, India.
Adarsh Aayilliath KDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Ankit MittalDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Naveet WigDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

India has the largest problem of tuberculosis (TB) infection globally (estimated at about 35-40 crores cases), and around 18-36 lakh develop active tuberculosis annually. Latent TB is defined as a state of persistent immune response to stimulation by

Indexed as

Antitubercular AgentsLatent TuberculosisMycobacterium tuberculosisHumansIndiaPractice Guidelines as TopicRisk FactorsWorld Health OrganizationAntitubercular Agentsantiretroviral therapyinfectionlatent tuberculosisMycobacterium tuberculosis.tuberculosisWorld Health organisation

Identifiers

PMID38031772
OpenAlexW4389180471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.